Bioxyne (ASX:BXN) Payments on Behalf of Employees : A$0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Payments on Behalf of Employees?

Bioxyne's Payments on Behalf of Employees for the six months ended in Dec. 2023 was A$0.00 Mil.

Bioxyne's Payments on Behalf of Employees for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00 Mil.

Bioxyne Payments on Behalf of Employees Historical Data

The historical data trend for Bioxyne's Payments on Behalf of Employees can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne Payments on Behalf of Employees Chart

Bioxyne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Payments on Behalf of Employees

Get a 7-Day Free Trial

Bioxyne Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Payments on Behalf of Employees	Get a 7-Day Free Trial															-	-	-	-	-

Bioxyne Payments on Behalf of Employees Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments on Behalf of Employees represents cash paid in a form of salaries or other benefits to employees of the company, in the direct cash flow method.

Payments on Behalf of Employees for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Bioxyne Payments on Behalf of Employees Related Terms

Thank you for viewing the detailed overview of Bioxyne's Payments on Behalf of Employees provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioxyne (ASX:BXN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Payments on Behalf of Employees

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000

Website

https://www.bioxyne.com

Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.

Bioxyne (ASX:BXN) Headlines

No Headlines